2013
DOI: 10.1016/j.jaip.2012.11.002
|View full text |Cite
|
Sign up to set email alerts
|

The Utility of Peanut Components in the Diagnosis of IgE-Mediated Peanut Allergy Among Distinct Populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
101
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 91 publications
(105 citation statements)
references
References 26 publications
2
101
0
2
Order By: Relevance
“…We found that purified Ara h 2 was sufficient to induce IgE production in mice, leading to anaphylaxis upon challenge, and could induce bystander sensitization, demonstrating inherent adjuvant activity. Ara h 2 is the dominant allergen in peanut, and component testing has indicated that IgE against Ara h 2 is predictive of clinical reactivity in patients (21). Interestingly, we did not observe innate effects of Ara h 2 on human keratinocytes (data not shown), and, unlike Ara h 1, Ara h 2 is not significantly glycosylated.…”
Section: Discussionmentioning
confidence: 55%
See 1 more Smart Citation
“…We found that purified Ara h 2 was sufficient to induce IgE production in mice, leading to anaphylaxis upon challenge, and could induce bystander sensitization, demonstrating inherent adjuvant activity. Ara h 2 is the dominant allergen in peanut, and component testing has indicated that IgE against Ara h 2 is predictive of clinical reactivity in patients (21). Interestingly, we did not observe innate effects of Ara h 2 on human keratinocytes (data not shown), and, unlike Ara h 1, Ara h 2 is not significantly glycosylated.…”
Section: Discussionmentioning
confidence: 55%
“…Despite the induction of antibody responses to Ara h 1 and Ara h 2, only mice exposed to Ara h 2 experienced significant anaphylactic reactions following intraperitoneal challenge (Supplemental Figure 5B). Ara h 2 is the component of peanut linked most closely to clinical reactivity in humans (21).…”
Section: Resultsmentioning
confidence: 99%
“…2,31,238 Studies of the clinical utility of CRD for specific allergens have shown promising results for a relatively small number of foods. Recent studies propose sIgE antibodies to Ara h 2 as the most common peanut allergen associated with clinical reactivity, [239][240][241] and sensitization to Ara h 1, 2, or 3 has been associated with increased severity of reactions in certain subjects, especially compared with those sensitized to Ara h 8 (Bet v 1 related), who experience predominantly oral allergy symptoms. 242 Similarly, sensitization to Cor a 9 and Cor a 14 has been associated with both symptom severity and objective findings during DBPCFCs to hazel nut.…”
Section: Section V: Adverse Reactions To Food Additivesmentioning
confidence: 99%
“…In this study, an Ara h 2 sIgE level of 0.55 kU/L was found to be 93 % sensitive and 100 % specific for PN allergy. Several additional studies, mostly in children, have found Ara h 2 to be the PN component most strongly associated with clinical reactivity, with higher levels of Ara h 2 sIgE correlating to a greater likelihood of clinical allergy [32][33][34][35][36].…”
Section: Peanut Allergymentioning
confidence: 99%
“…Among the known components, Ara h 2 has been shown in multiple studies to be the most important predictor of clinical reactivity, though Ara h 1, 3, and 6 have also been associated with severe reactions [32][33][34][35][36][37]. Ara h 9 has been correlated with mild to severe symptoms in Mediterranean patients [30•, 38].…”
Section: Peanut Allergymentioning
confidence: 99%